Katja Pokrovskaja Tamm (K Pokrovskaja Tamm)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Svea Stratmann, Mattias Vesterlund, Husen M Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Krogh Herlin, Christian Hartmann Geisler, Anna Ulrika Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe-Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia 37 (3) (2022)
Svea Stratmann, Mattias Vesterlund, Husen M Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Krogh Herlin, Christian Hartmann Geisler, Anna Ulrika Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe-Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia 37 (3) (2022)
Isabelle Rose Leo, Luay Aswad, Matthias Stahl, Elena Kunold, Frederik Post, Tom Erkers, Nona Struyf, Georgios Mermelekas, Rubin Narayan Joshi, Eva Gracia Villacampa, Päivi Östling, Olli P Kallioniemi, Katja Pokrovskaja Tamm, Ioannis Siavelis, Janne Lehtiö, Mattias Vesterlund, Rozbeh Jafari
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. Nature communications 13 (1) (2022)
Svea Stratmann, Mattias Vesterlund, Husen M Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Krogh Herlin, Christian Hartmann Geisler, Anna Ulrika Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe-Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia 37 (3) (2022)
Svea Stratmann, Mattias Vesterlund, Husen M Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Krogh Herlin, Christian Hartmann Geisler, Anna Ulrika Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe-Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia 37 (3) (2022)
Svea Stratmann, Mattias Vesterlund, Husen M Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Krogh Herlin, Christian Hartmann Geisler, Anna Ulrika Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe-Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia (2022)
Sander Busker, W Qian, M Haraldsson, B Espinosa, L Johansson, S Attarha, I Kolosenko, J Liu, M Dagnell, D Grandér, Elias S J Arnér, Katja Pokrovskaja Tamm, Brent D G Page
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death. Science advances 6 (12) (2020)
Elin Edsbäcker, Jason T Serviss, Iryna Kolosenko, Caroline Palm-Apergi, Angelo De Milito, Katja Pokrovskaja Tamm
STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes. Scientific reports 9 (1) (2019)
Matheus Dyczynski, Mattias Vesterlund, Ann-Charlotte Björklund, Vasilios Zachariadis, Jerry Janssen, Hector Gallart-Ayala, Evangelia Daskalaki, Craig E Wheelock, Janne Lehtiö, Dan Grandér, Katja Pokrovskaja Tamm, Roland Nilsson
Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment. Cell death & disease 9 (9) (2018)
Jason T Serviss, Nathanael Andrews, Jimmy Van den Eynden, Felix Clemens Richter, Miranda Houtman, Mattias Vesterlund, Laura Schwarzmueller, Per Johnsson, Erik Larsson, Dan Grandér, Katja Pokrovskaja Tamm
An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a. Cell death & disease 9 (7) (2018)

Katja Pokrovskaja Tamm.css-eqlu8i{font-size:small;padding-left:4px;} (K Pokrovskaja Tamm)

Publication Activity (10 Years)

Top Topics

Top Venues

Katja Pokrovskaja Tamm (K Pokrovskaja Tamm)